Health Condition 1: L648- Other androgenic alopecia
Conditions
Interventions
Intervention1: 1.ORAL MINOXIDIL 2.ORAL DUTASTERIDE
: ORAL MINOXIDIL 5 MG FOR 12 MONTHS
ORAL DUTASTERIDE 0.5 MG FOR 12 MONTHS
Intervention2: 1. ORAL DUTASTERIDE: 0.5 MG WEEKLY THRICE FOR 12 MONTHS
Co
Sponsors
ANJANA GOPALAKRISHNAN
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male patients aged 18-30 years with clinical features suggestive of Androgenetic alopecia(MPHL) 2.Patients with AGA Grade 1-5 of modified Hamilton-Norwood scale. 3.Person who has not taken medical treatment for AGA in any form for the past 3 months.
Exclusion criteria
Exclusion criteria: 1.Male patients with alopecia secondary to known endocrinological disorders. 2.Male patients with other non scarring alopecias 3.Elderly patients with severe hypertension associated with other cardiovascular problems.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Assessment of hair growth with Global Photographic Assessment scale. 2.Assessment of side effects of oral minoxidil and oral dutasteride.Timepoint: Serial photographs of vertex and frontal areas to assess for improvement in hair growth at baseline, 3 months, 6 months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Assessment of hair growth with Global Photographic Assessment scale & patient satisfaction. 2.Assessment of efficacy of oral minoxidil & oral dutasteride using Global Photographic Assessment ScaleTimepoint: 1.Grading of improvement in hair growth at baseline,12 weeks,24 weeks,36 weeks & 48 weeks. 2.Serial photographs of vertex & frontal areas to assess for improvement in hair growth at baseline, 3 months, 6 months & 12 months. | — |
Countries
India
Contacts
Public ContactAnjana Gopalakrishnan
Sri Devaraj Urs Academy of Higher Education and Research, Kolar.
Outcome results
None listed